Cargando…
POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinoma
Radiotherapy is the primary means of treatment for patients with head and neck squamous cell carcinoma (HNSCC); however, radioresistance-induced recurrence is the primary cause of HNSCC treatment failure. Therefore, identifying specific predictive biomarkers of the response to radiotherapy may impro...
Autores principales: | He, Xu, Xu, Hongfa, Zhao, Wei, Zhan, Meixiao, Li, Yong, Liu, Hongyi, Tan, Li, Lu, Ligong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781657/ https://www.ncbi.nlm.nih.gov/pubmed/31612055 http://dx.doi.org/10.3892/ol.2019.10888 |
Ejemplares similares
-
LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023) -
FN1 promotes prognosis and radioresistance in head and neck squamous cell carcinoma: From radioresistant HNSCC cell line to integrated bioinformatics methods
por: Tang, Xiaojun, et al.
Publicado: (2022) -
Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck
por: Jing, Qiancheng, et al.
Publicado: (2019) -
Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2016) -
Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)